Is EXROF or MRK a better dividend investment in 2026?

EXROF currently yields 200000.00% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: EXROF offers higher current income.

What is the dividend yield difference between EXROF and MRK?

EXROF has a forward dividend yield of 200000.00% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 199997.24 percentage points.

Home › Compare › EXROF vs MRK

EXROF vs MRK: Dividend Comparison 2026

EXROF yields 200000.00% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EXROF wins by $4.911780474428384e+29M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EXROF

● Live price

200000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.911780474428384e+29M

Annual income

$490,695,411,370,591,700,000,000,000,000,000,000.00

Full EXROF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — EXROF vs MRK

📍 EXROF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EXROF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EXROF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EXROF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EXROF

Annual income on $10K today (after 15% tax)

$17,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$417,091,099,665,002,940,000,000,000,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, EXROF beats the other by $417,091,099,665,002,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EXROF + MRK for your $10,000?

EXROF: 50%MRK: 50%

100% MRK50/50100% EXROF

Portfolio after 10yr

$2.455890237214192e+29M

Annual income

$245,347,705,685,295,860,000,000,000,000,000,000.00/yr

Blended yield

99.90%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EXROF

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-21.9

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EXROF buys

MRK buys

No recent congressional trades found for EXROF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEXROFMRK

Forward yield	200000.00% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$4.911780474428384e+29M	$56.8K ✓
Annual income after 10y	$490,695,411,370,591,700,000,000,000,000,000,000.00 ✓	$9,798.13
Total dividends collected	$4.911464459982279e+29M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy

Year-by-year: EXROF vs MRK ($10,000, DRIP)

Year	EXROF Portfolio	EXROF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$20,010,700	$20,000,000.00	$11,206	$366.19	+$20.00M → EXROF
2	$37,424,589,019	$37,403,177,570.09	$12,650	$502.35	+$37424.58M → EXROF
3	$65,416,215,188,220	$65,376,170,877,969.18	$14,407	$694.19	+$65416215.17M → EXROF
4	$106,868,230,495,008,900	$106,798,235,144,757,520.00	$16,585	$967.82	+$106868230494.99M → EXROF
5	$163,172,871,735,896,870,000	$163,058,522,729,267,200,000.00	$19,342	$1,363.89	+$163172871735896.84M → EXROF
6	$232,854,599,801,468,860,000,000	$232,680,004,828,711,460,000,000.00	$22,913	$1,947.19	+$232854599801468864.00M → EXROF
7	$310,570,858,137,017,100,000,000,000	$310,321,703,715,229,540,000,000,000.00	$27,662	$2,823.89	+$310570858137017057280.00M → EXROF
8	$387,148,154,301,613,200,000,000,000,000	$386,815,843,483,406,600,000,000,000,000.00	$34,159	$4,173.35	+$3.871481543016132e+23M → EXROF
9	$451,061,749,763,281,040,000,000,000,000,000	$450,647,501,238,178,360,000,000,000,000,000.00	$43,337	$6,308.80	+$4.510617497632811e+26M → EXROF
10	$491,178,047,442,838,440,000,000,000,000,000,000	$490,695,411,370,591,700,000,000,000,000,000,000.00	$56,776	$9,798.13	+$4.911780474428384e+29M → EXROF

EXROF vs MRK: Complete Analysis 2026

EXROF — Stock

Exro Technologies Inc. focuses on developing and commercializing patented coil driver technology and proprietary system architecture for power electronics. The company's technology expands the capabilities of electric motors, generators, and batteries. It also develops the battery control system that provides energy storage system solutions for first and second life batteries. Exro Technologies Inc. was incorporated in 2014 and is headquartered in Calgary, Canada.

Full EXROF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this EXROF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EXROF vs SCHD EXROF vs JEPI EXROF vs O EXROF vs KO EXROF vs MAIN EXROF vs JNJ EXROF vs ABBV EXROF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.